A further study of the antagonistic action between alpha and beta blocking agents.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D002415:Cats; D004837:Epinephrine / Q000037:antagonists & inhibitors; D008729:Methoxamine / Q000037:antagonists & inhibitors; D009541:Nictitating Membrane / Q000187:drug effects; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D010109:Oxymetazoline / Q000037:antagonists & inhibitors; D010643:Phenoxybenzamine / Q000494:pharmacology; D010656:Phenylephrine / Q000037:antagonists & inhibitors; D010879:Piperazines / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology*; D013566:Sympathomimetics / Q000008:administration & dosage*; D014439:Tyramine / Q000037:antagonists & inhibitors
D010879:Piperazines; D013565:Sympatholytics; D013566:Sympathomimetics; D010643:Phenoxybenzamine; D010656:Phenylephrine; D010109:Oxymetazoline; D011433:Propranolol; D008729:Methoxamine; D009638:Norepinephrine; D014439:Tyramine; D004837:Epinephrine